Fragile X syndrome: An aging perspective

Developmental Disabilities Research Reviews

Volumn 18, Issue 1, 2013, Pages 68-74

  Schneider, Andrea ^a,b   Ligsay, Andrew ^a,b   Hagerman, Randi J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; FMRP; Fragile X syndrome; Neurodegeneration

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN;

AGING; ARTICLE; AUTISM; COGNITION; FRAGILE X SYNDROME; GENE MUTATION; HUMAN; INTELLECTUAL IMPAIRMENT; INTELLIGENCE QUOTIENT; MENTAL DETERIORATION; PHENOTYPE; PRIORITY JOURNAL;

AGING; FMRP; FRAGILE X SYNDROME; NEURODEGENERATION;

AGING; CEREBELLAR DISEASES; CHILD DEVELOPMENT DISORDERS, PERVASIVE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; INTELLECTUAL DISABILITY; MOSAICISM;

EID: 84893491304     PISSN: 19405510     EISSN: 19405529     Source Type: Journal    
DOI: 10.1002/ddrr.1129     Document Type: Article

References (139)

1. Adams JS, Adams PE, Nguyen D, et al. 2007. Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS). Neurology 69:851-859.
2. Akaaboune M, Allinquant B, Farza H, et al. 2000. Developmental regulation of amyloid precursor protein at the neuromuscular junction in mouse skeletal muscle. Mol Cell Neurosci 15:355-367.
3. Allen EG, He W, Yadav-Shah M, et al. 2004. A study of the distributional characteristics of FMR1 transcript levels in 238 individuals. Hum Genet 114:439-447.
4. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders, 4th edition (DSM-IV). Washington, DC: American Psychiatric Association.
5. Amiri K, Hagerman RJ, Hagerman PJ. 2008. Fragile X-associated tremor/ataxia syndrome: an aging face of the fragile X gene. Arch Neurol 65:19-25.
6. Bailey A, Luthert P, Dean A, et al. 1998. A clinicopathological study of autism. Brain 121(Pt 5):889-905.
7. Bassell GJ, Warren ST. 2008. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 60:201-214.
8. Bauman M, Kemper TL. 1985. Histoanatomic observations of the brain in early infantile autism. Neurology 35:866-874.
9. Beadle-Brown J, Murphy G, Wing L, et al. 2000. Changes in skills for people with intellectual disability: a follow-up of the Camberwell Cohort. J Intellect Disabil Res 44(Pt 1):12- 24.
10. Bear MF. 2005. Therapeutic implications of the mGluR theory of fragile X mental retardation. Genes Brain Behav 4:393-398.
11. Bear MF, Huber KM, Warren ST. 2004. The mGluR theory of fragile X mental retardation. Trends Neurosci 27:370-377.
12. Berry-Kravis E, Hessl D, Coffey S, et al. 2009. A pilot open label, single dose trial of fenobam in adults with fragile X syndrome. J Med Genet 46:266-271.
13. Berry-Kravis E, Knox A, Hervey C. 2011. Targeted treatments for fragile X syndrome. J Neurodev Disord 54:39.
14. Bolte S, Adam-Schwebe S, Englert E, et al. 2000. [Utilization of psychological tests for diagnosis in German child and adolescent psychiatry: results of a survey]. Z Kinder Jugendpsychiatr Psychother, 28:151-161.
15. Borghgraef M, Van Buggenhout G, Volvke P, et al. 2002. Aging in Fragile X: followup data in adult fragile X males. Paper presented at the 10th International Workshop on fragile X and X linked mental retardation, September 19-22, 2001, Frascati, Italy.
16. Bourgeois JA, Coffey SM, Rivera SM, et al. 2009. A review of fragile X premutation disorders: expanding the psychiatric perspective. J Clin Psychiatry, 70:852-862.
17. Brega AG, Goodrich G, Bennett RE, et al. 2008. The primary cognitive deficit among males with fragile X-associated tremor/ataxia syndrome (FXTAS) is a dysexecutive syndrome. J Clin Exp Neuropsychol 30:853-869.
18. Brouwer JR, Severijnen E, de Jong FH, et al. 2008. Altered hypothalamus-pituitaryadrenal gland axis regulation in the expanded CGG-repeat mouse model for fragile X-associated tremor/ataxia syndrome. Psychoneuroendocrinology 33:863-873.
19. Brun C, Obiols JE, Cheema A, et al. 1995. Longitudinal IQ changes in fragile X females. Dev Brain Dysfunct 8:280-292.
20. Budimirovic DB, Bukelis I, Cox C, et al. 2006. Autism spectrum disorder in Fragile X syndrome: differential contribution of adaptive socialization and social withdrawal. Am J Med Genet A, 140A:1814-1826.
21. Chonchaiya W, Au J, Schneider A, et al. 2011. Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder. Hum Genet 131:581-589.
22. Clifford S, Dissanayake C, Bui QM, et al. 2007. Autism spectrum phenotype in males and females with fragile X full mutation and premutation. J Autism Dev Disord 37:738-747.
23. Coffey SM, Cook K, Tartaglia N, et al. 2008. Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A 146A:1009-1016.
24. Comery TA, Harris JB, Willems PJ, et al. 1997. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci USA 94:5401- 5404.
25. Cornish KM, Li L, Kogan CS, et al. 2008. Agedependent cognitive changes in carriers of the fragile X syndrome. Cortex 44:628-636.
26. Courchesne E, Saitoh O, Yeung-Courchesne R, et al. 1994a. Abnormality of cerebellar vermian lobules VI and VII in patients with infantile autism: identification of hypoplastic and hyperplastic subgroups with MR imaging. AJR Am J Roentgenol 162:123-130.
27. Courchesne E, Townsend J, Saitoh O. 1994b. The brain in infantile autism: posterior fossa structures are abnormal. Neurology 44:214- 223.
28. Courchesne E, Yeung-Courchesne R, Press GA, et al. 1988. Hypoplasia of cerebellar vermal lobules VI and VII in autism. N Engl J Med 318:1349-1354.
29. Cummings DE, Clement K, Purnell JQ, et al. 2002. Elevated plasma ghrelin levels in Prader-Willi syndrome. Nat Med 8:643-644.
30. Darnell JC, Van Driesche SJ, Zhang C, et al. 2011. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146:247-261.
31. de Vrij FM, Levenga J, van der Linde HC, et al. 2008. Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice. Neurobiol Dis 31:127-132.
32. Desai HB, Donat J, Shokeir MH, et al. 1990. Amyotrophic lateral sclerosis in a patient with fragile X syndrome. Neurology 40:378-380.
33. Dombrowski C, Levesque ML, Morel ML, et al. 2002. Premutation and intermediate-size FMR1 alleles in 10 572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Hum Mol Genet 11:371- 378.
34. Dunn H, Renpenning H, Gerrard J, et al. 1963. Mental retardation as a sex-linked defect. Am J Ment Defic 67:827-848.
35. Dykens EM, Hodapp RM, Ort S, et al. 1989. The trajectory of cognitive development in males with fragile X syndrome. J Am Acad Child Adolesc Psychiatry 28:422-426.
36. Dykens EM, Hodapp RM, Ort SI, et al. 1993. Trajectory of adaptive behavior in males with fragile X syndrome. J Autism Dev Disord 23:135-145.
37. Eberhart DE, Malter HE, Feng Y, et al. 1996. The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum Mol Genet 5:1083-1091.
38. Einfeld S, Tonge B, Turner G. 1999. Longitudinal course of behavioral and emotional problems in fragile X syndrome. Am J Med Genet 87:436-439.
39. El Bekay R, Romero-Zerbo Y, Decara J, et al. 2007. Enhanced markers of oxidative stress, altered antioxidants and NADPH-oxidase activation in brains from Fragile X mental retardation 1-deficient mice, a pathological model for Fragile X syndrome. Eur J Neurosci 26:3169-3180.
40. Farzin F, Perry H, Hessl D, et al. 2006. Autism spectrum disorders and attention-deficit/ hyperactivity disorder in boys with the fragile X premutation. J Dev Behav Pediatr 27(2 Suppl):S137-S144.
41. Fendt M, Schmid S. 2002. Metabotropic glutamate receptors are involved in amygdaloid plasticity. Eur J Neurosci 15:1535-1541.
42. Fernandez-Carvajal I, Walichiewicz P, Xiaosen X, et al. 2009. Screening for expanded alleles of the FMR1 gene in blood spots from newborn males in a Spanish population. J Mol Diagn 11:324-329.
43. Fisch GS, Shapiro LR, Simensen R, et al. 1992. Longitudinal changes in IQ among fragile X males: clinical evidence of more than one mutation? Am J Med Genet 43:28-34.
44. Fisch GS, Simensen R, Arinami T, et al. 1994. Longitudinal changes in IQ among fragile X females: a preliminary multicenter analysis. Am J Med Genet 51: 353-357.
45. Fisch GS, Simensen RJ, Schroer RJ. 2002. Longitudinal changes in cognitive and adaptive behavior scores in children and adolescents with the fragile X mutation or autism. J Autism Dev Disord 32:107-114.
46. Franke P, Leboyer M, Gansicke M, et al. 1998. Genotype-phenotype relationship in female carriers of the premutation and full mutation of FMR-1. Psychiatry Res 80:113-127.
47. Franke P, Maier W, Hautzinger M, et al. 1996. Fragile-X carrier females: evidence for a distinct psychopathological phenotype? Am J Med Genet 64:334-339.
48. Garcia-Arocena D, Hagerman PJ. 2010. Advances in understanding the molecular basis of FXTAS. Hum Mol Genet 19(R1):R83- R89.
49. Gilchrist A, Green J, Cox A, et al. 2001. Development and current functioning in adolescents with Asperger syndrome: a comparative study. J Child Psychol Psychiatry 42:227-240.
50. Gillberg C, Steffenburg S. 1987. Outcome and prognostic factors in infantile autism and similar conditions: a population-based study of 46 cases followed through puberty. J Autism Dev Disord 17:273-287.
51. Gokden M, Al-Hinti JT, Harik SI. 2009. Peripheral nervous system pathology in fragile X tremor/ataxia syndrome (FXTAS). Neuropathology 29:280-284.
52. Greco CM, Berman RF, Martin RM, et al. 2006. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 129(Pt 1):243-255.
53. Greco CM, Hagerman RJ, Tassone F, et al. 2002. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 125: 1760-1771.
54. Greco CM, Soontarapornchai K, Wirojanan J, et al. 2007. Testicular and pituitary inclusion formation in fragile X associated tremor/ ataxia syndrome. J Urol 177:1434-1437.
55. Grigsby J, Brega AG, Engle K, et al. 2008. Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ataxia syndrome. Neuropsychology 22:48-60.
56. Grigsby J, Brega AG, Leehey MA, et al. 2007. Impairment of executive cognitive functioning in males with fragile X-associated tremor/ataxia syndrome. Mov Disord 22: 645-650.
57. Hagerman PJ. 2008. The fragile X prevalence paradox. J Med Genet 45:498-499.
58. Hagerman PJ, Hagerman RJ. 2004a. The fragile-X premutation: a maturing perspective. Am J Hum Genet 74:805-816.
59. Hagerman PJ, Hagerman RJ. 2004b. Fragile Xassociated Tremor/Ataxia Syndrome (FXTAS). Ment Retard Dev Disabil Res Rev 10:25-30.
60. Hagerman RJ. 2002. Physical and behavioral phenotype. In Hagerman RJ, Hagerman PJ, editors. Fragile X syndrome: diagnosis, treatment and research, 3rd ed. Baltimore: The Johns Hopkins University Press. p 3-109.
61. Hagerman RJ, Greco C, Chudley A, et al. 2001. Neuropathology and neurodegenerative features in some older male premutation carriers of fragile X syndrome. Am J Hum Genet Suppl 69:177.
62. Hagerman RJ, Leehey M, Heinrichs W, et al. 2001. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57:127-130.
63. Hagerman RJ, Schreiner RA, Kemper MB, et al. 1989. Longitudinal IQ changes in fragile X males. Am J Med Genet 33:513-518.
64. Hall D, Pickler L, Riley K, et al. 2010. Parkinsonism and cognitive decline in a fragile X mosaic male. Mov Disord 25:1523-1524.
65. Hall SS, Burns DD, Lightbody AA, et al. 2008. Longitudinal changes in intellectual development in children with fragile x syndrome. J Abnorm Child Psychol 36:927-939.
66. Harris SW, Hessl D, Goodlin-Jones B, et al. 2008. Autism profiles of males with fragile X syndrome. Am J Ment Retard 113: 427-438.
67. Hernandez RN, Feinberg RL, Vaurio R, et al. 2009. Autism spectrum disorder in fragile X syndrome: a longitudinal evaluation. Am J Med Genet A 149A:1125-1137.
68. Hinton VJ, Brown WT, Wisniewski K, et al. 1991. Analysis of neocortex in three males with the fragile X syndrome. Am J Med Genet 41:289-294.
69. Hodapp RM, Dykens EM, Ort SI, et al. 1991. Changing patterns of intellectual strengths and weaknesses in males with fragile X syndrome. J Autism Dev Disord 21:503-516.
70. Hoeffer CA, Klann E. 2010. mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci 33:67-75.
71. Hunsaker MR, Greco CM, Spath MA, et al. 2011. Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor/ataxia syndrome and CGG knock-in mice. Acta Neuropathol 122:467-479.
72. Irwin SA, Galvez R, Greenough WT. 2000. Dendritic spine structural anomalies in fragile-X mental retardation syndrome. Cereb Cortex 10:1038-1044.
73. Irwin SA, Idupulapati M, Gilbert ME, et al. 2002. Dendritic spine and dendritic field characteristics of layer V pyramidal neurons in the visual cortex of fragile-X knockout mice. Am J Med Genet 111:140-146.
74. Jacquemont S, Curie A, des Portes V, et al. 2011. Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Sci Transl Med 3:64ra61.
75. Jacquemont S, Hagerman RJ, Leehey M, et al. 2003. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet 72: 869-878.
76. Kamenetz F, Tomita T, Hsieh H, et al. 2003. APP processing and synaptic function. Neuron 37:925-937.
77. Kau AS M, Tierney E, Bukelis I, et al. 2004. Social behavior profile in young males with fragile X syndrome: characteristics and specificity. Am J Med Genet 126A:9-17.
78. Kaufmann WE, Cortell R, Kau AS, et al. 2004. Autism spectrum disorder in fragile X syndrome: communication, social interaction, and specific behaviors. Am J Med Genet 129A:225-234.
79. Kenneson A, Zhang F, Hagedorn CH, et al. 2001. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet 10:1449-1454.
80. Kim J, Alger BE. 2010. Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. Nat Neurosci 13:592-600.
81. Kobayashi R, Murata T. 1998. Behavioral characteristics of 187 young adults with autism. Psychiatry Clin Neurosci 52:383-390.
82. Lachiewicz AM, Gullion C, Spiridigliozzi G, et al. 1987. Declining IQs of young males with the fragile X syndrome. Am J Ment Retard 92:272-278.
83. Leehey MA, Berry-Kravis E, Goetz CG, et al. 2011. Clinical neurological phenotype of FXTAS. In: Tassone F, Berry-Kravis E, editors. The fragile X-associated tremor ataxia syndrome (FXTAS). New York: Springer. p 1-16.
84. Leehey MA, Berry-Kravis E, Min S. J, et al. 2007. Progression of tremor and ataxia in male carriers of the FMR1 premutation. Mov Disord 22:203-206.
85. Loesch DZ, Huggins RM, Hagerman RJ. 2004. Phenotypic variation and FMRP levels in fragile X. Ment Retard Dev Disabil Res Rev 10:31-41.
86. Loesch DZ, Sherwell S, Kinsella G, et al. 2011. Fragile X-associated tremor/ataxia phenotype in a male carrier of unmethylated full mutation in the FMR1 gene. Clin Genet 82:88-92.
87. Lord C, Rutter M, Le Couteur A. 1994. Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24:659-685.
88. Louis E, Moskowitz C, Friez M, et al. 2006. Parkinsonism, dysautonomia, and intranuclear inclusions in a fragile X carrier: a clinicalpathological study. Mov Disord 21:420-425.
89. Luo Y, Shan G, Guo W, et al. 2010. Fragile X mental retardation protein regulates proliferation and differentiation of adult neural stem/progenitor cells. PLoS Genet 6: e1000898.
90. McBride SM, Choi CH, Wang Y, et al. 2005. Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome. Neuron 45:753-764.
91. Napoli E, Ross-Inta C, Wong S, et al. 2011. Altered zinc transport disrupts mitochondrial protein processing/import in fragile Xassociated tremor/ataxia syndrome. Hum Mol Genet 20:3079-3092.
92. Nikolaev A, McLaughlin T, O'Leary DD, et al. 2009. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 457:981-989.
93. Partington MW, Robinson H, Laing S, et al. 1992. Mortality in the fragile X syndrome: preliminary data. Am J Med Genet 43:120- 123.
94. Penagarikano O, Mulle JG, Warren ST. 2007. The pathophysiology of fragile X syndrome. Annu Rev Genom Hum Genet 8:109-129.
95. Pfeiffer BE, Huber KM. 2009. The state of synapses in fragile X syndrome. Neuroscientist 15:549-567.
96. Piven J, Harper J, Palmer P, et al. 1996. Course of behavioral change in autism: a retrospective study of high-IQ adolescents and adults. J Am Acad Child Adolesc Psychiatry 35: 523-529.
97. Primerano B, Tassone F, Hagerman RJ, et al. 2002. Reduced FMR1 mRNA translation efficiency in Fragile X patients with premutations. RNA 8:1482-1488.
98. Reiss AL, Abrams MT, Greenlaw R, et al. 1995. Neurodevelopmental effects of the FMR1 full mutation in humans. Nat Med 1:159- 167.
99. Reiss AL, Lee J, Freund L. 1994. Neuroanatomy of fragile X syndrome: the temporal lobe. Neurology 44:1317-1324.
100. Reiss AL, Patel S, Kumar AJ, et al. 1988. Preliminary communication: neuroanatomical variations of the posterior fossa in men with the fragile X (Martin-Bell) syndrome. Am J Med Genet 31:407-414.
101. Roberts JE, Bailey DB Jr, Mankowski J, et al. 2008. Mood and anxiety disorders in females with the FMR1 premutation. Am J Med Genet B Neuropsychiatr Genet 150B:130- 139.
102. Rodriguez-Revenga L, Madrigal I, Pagonabarraga J, et al. 2009. Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families. Eur J Hum Genet 17: 1359-1362.
103. Rogers SJ, Wehner EA, Hagerman RJ. 2001. The behavioral phenotype in fragile X: symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders. J Dev Behav Pediatr 22:409-417.
104. Ross-Inta C, Omanska-Klusek A, Wong S, et al. 2010. Evidence of mitochondrial dysfunction in fragile X-associated tremor/ataxia syndrome. Biochem J 429:545-552.
105. Rudelli RD, Brown WT, Wisniewski K, et al. 1985. Adult fragile X syndrome. Cliniconeuropathologic findings. Acta Neuropathol 67:289-295.
106. Rumsey JM, Rapoport JL, Sceery WR. 1985. Autistic children as adults: psychiatric, social, and behavioral outcomes. J Am Acad Child Psychiatry 24:465-473.
107. Sabaratnam M. 2000. Pathological and neuropathological findings in two males with fragile X syndrome. J Intellect Disabil Res 44:81-85.
108. Seltzer MM, Krauss MW, Orsmond G, et al. 2001. Families of adolescents and adults with autism: uncharted territory. Int Rev Res Mental Retard 23:267-294.
109. Seltzer MM, Krauss MW, Shattuck PT, et al. 2003. The symptoms of autism spectrum disorders in adolescence and adulthood. J Autism Develop Disord 33:565-581.
110. Seritan AL, Nguyen DV, Farias ST, et al. 2008. Dementia in fragile X-associated tremor/ ataxia syndrome (FXTAS): comparison with Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 147B:1138-1144.
111. Sharma A, Hoeffer CA, Takayasu Y, et al. 2010. Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci 30:694-702.
112. Sobesky WE. 1996. The Treatment of Emotional and Behavioral Problems. In: Hagerman RJ, Cronister A, editors. Fragile X syndrome: diagnosis, treatment, and research, 2nd ed. Baltimore: The Johns Hopkins University Press. p 332-348.
113. Sokol DK, Maloney B, Long JM, et al. 2011. Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links. Neurology 76:1344-1352.
114. Soontarapornchai K, Maselli R, Fenton-Farrell G, et al. 2008. Abnormal nerve conduction features in fragile X premutation carriers. Arch Neurol 65:495-498.
115. Sutcliffe JS, Nelson DL, Zhang F, et al. 1992. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet 1:397-400.
116. Tassone F. 2010. mTOR up-regulation in patients with FXS [abstract]. Paper presented at the FRAXA Investigators meeting, May 2-5, Durham, NH.
117. Tassone F, Adams J, Berry-Kravis EM, et al. 2007. CGG repeat length correlates with age of onset of motor signs of the fragile Xassociated tremor/ataxia syndrome (FXTAS). Am J Med Genet B Neuropsychiatr Genet 144:566-569.
118. Tassone F, Beilina A, Carosi C, et al. 2007. Elevated FMR1 mRNA in premutation carriers is due to increased transcription. RNA 13: 555-562.
119. Tassone F, Hagerman RJ, Ikle DN, et al. 1999. FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Med Genet 84:250-261.
120. Tassone F, Hagerman RJ, Taylor AK, et al. 2000. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet 66:6-15.
121. Tassone F, Hagerman RJ, Taylor AK, et al. 2001. A majority of fragile X males with methylated, full mutation alleles have significant levels of FMR1 messenger RNA. J Med Genet 38:453-456.
122. Tucker B, Richards RI, Lardelli M. 2006. Contribution of mGluR and Fmr1 functional pathways to neurite morphogenesis, craniofacial development and fragile X syndrome. Hum Mol Genet 15:3446-3458.
123. Turk J. 2011. Fragile X syndrome: lifespan developmental implications for those without as well as with intellectual disability. Curr Opin Psychiatry 24:387-397.
124. Utari A, Adams E, Berry-Kravis E, et al. 2010. Aging in fragile X syndrome. J Neurodev Disord 2:70-76.
125. Venter A, Lord C, Schopler E. 1992. A follow-up study of high-functioning autistic children. J Child Psychol Psychiatry 33:489-507.
126. Wang DO, Martin KC, Zukin RS. 2010. Spatially restricting gene expression by local translation at synapses. Trends Neurosci 33: 173-182.
127. Wang LW, Berry-Kravis E, Hagerman RJ. 2010. Fragile X: leading the way for targeted treatments in autism. Neurotherapeutics 7: 264-274.
128. Weiler IJ, Irwin SA, Klintsova AY, et al. 1997. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci USA 94:5395-5400.
129. Westmark CJ, Malter JS. 2007. FMRP mediates mGluR5-dependent translation of amyloid precursor protein. PLoS Biol 5:e52.
130. Westmark CJ, Westmark PR, Malter JS. 2010. Alzheimer's disease and Down syndrome rodent models exhibit audiogenic seizures. J Alzheimers Dis 20:1009-1013.
131. WHO. 1992. International statistical classification of diseases and related health problems (ICD-10), 1989 [Revision].
132. Wiegers AM, Curfs LM, Fryns JP. 1992. A longitudinal study of intelligence in Dutch fragile X boys. Birth Defects 28:93-97.
133. Wiegers AM, Curfs LM, Vermeer EL, et al. 1993. Adaptive behavior in the fragile X syndrome: profile and development. Am J Med Genet 47:216-220.
134. Willemsen R, Bontekoe C, Tamanini F, et al. 1996. Association of FMRP with ribosomal precursor particles in the nucleolus. Biochem Biophys Res Commun 225:27-33.
135. Willemsen R, Hoogeveen-Westerveld M, Reis S, et al. 2003. The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions: implications for the cerebellar tremor/ataxia syndrome. Hum Mol Genet 12:949-959.
136. Wilson BM, Cox CL. 2007. Absence of metabotropic glutamate receptor-mediated plasticity in the neocortex of fragile X mice. Proc Natl Acad Sci USA 104:2454-2459.
137. Wright Talamante C, Cheema A, Riddle JE, et al. 1996. A controlled study of longitudinal IQ changes in females and males with fragile X syndrome. Am J Med Genet 64:350-355.
138. Yan QJ, Rammal M, Tranfaglia M, et al. 2005. Suppression of two major fragile X syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology 49:1053-1066.
139. Zhang L, Alger BE. 2010. Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome. J Neurosci 30: 5724-5729.